Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,751.90
(
-0.20%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 112128

Monday, 07/23/2012 4:31:53 PM

Monday, July 23, 2012 4:31:53 PM

Post# of 257268
FDA approves Tudorza Pressair from FRX/Almirall for COPD maintenance:

http://finance.yahoo.com/news/forest-laboratories-almirall-announce-fda-200000625.html

Tudorza Pressair (f/k/a aclidinium bromide) is a BID-dosed LAMA. How it will confer sufficient differentiation in the marketplace is unclear to me. FDA approval was expected insofar as an advisory panel voted 12-2 in favor in Feb 2012 (#msg-72477706).

p.s. The product name sounds like a centralized vacuum system that has been optimized for use in oversized Tudor houses.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today